How World War Ii Rationing Accidentally Proved B Vitamins Matter For Brain Function

How World War II Rationing Accidentally Proved B Vitamins Matter for Your Brain

It is 1940, and Britain is at war. Food is scarce. Meat, eggs, dairy, the rich dietary sources of B vitamins that most people had taken entirely for granted, are rationed to a fraction of their pre-war quantities. Government scientists, already stretched thin by the demands of wartime medicine, begin noticing something troubling in the population data. Neurological problems. Cognitive decline. Mood disturbances. And they start to wonder: could what people are *not* eating be doing something to their brains?

What followed over the next eight decades is one of the most compelling, and still unfolding, stories in nutritional neuroscience. Researchers weren’t looking for a brain health breakthrough when they began studying wartime malnutrition. They were trying to understand why people were getting sick. But in doing so, they accidentally handed science one of its most important natural experiments: a real-world, population-scale demonstration of what happens to the human brain when B vitamins run low.

Here’s what decades of research has taught us, and what it means for you today.

The Science Behind B Vitamins and Your Brain

To understand why B vitamins matter so much for the brain, you need to know what they actually *do* inside it.

Think of B vitamins not as a single thing, but as a family of essential co-workers, each one responsible for a different critical job in keeping your brain running properly. Vitamin B1 (thiamine) is the brain’s fuel manager. Your brain runs almost exclusively on glucose, and thiamine is essential for the enzymes that convert that glucose into usable energy [4]. Without it, your brain’s power supply begins to fail.

Vitamins B6, B9 (folate) and B12 work together on something called the methylation cycle, a biochemical process that affects everything from DNA repair to the production of neurotransmitters like serotonin and dopamine [7]. One of the most important outputs of this cycle is the regulation of a compound called homocysteine. When B vitamin status is adequate, homocysteine is safely recycled. When B vitamins are low, homocysteine builds up in the blood, and elevated homocysteine is directly toxic to brain tissue, damages blood vessels supplying the brain, and is strongly associated with brain shrinkage and dementia [2, 6].

Vitamin B6 plays an additional role in regulating the noradrenergic system, the brain’s stress-response signalling network. When B6 is deficient, this system becomes overactive, which researchers have linked to social difficulties and cognitive impairment [8].

B12, meanwhile, is critical for maintaining the myelin sheaths that insulate your nerve fibres, essentially the protective coating around the brain’s wiring [5]. Damage to that coating slows and scrambles neural signals.

Put it all together, and B vitamins are not peripheral to brain health. They are embedded in its most fundamental operations: energy production, cellular repair, neurotransmitter synthesis, structural protection, and vascular health.

Finding 1: Thiamine Deficiency and the Brain, A Century of Evidence

Evidence grade: Strong for deficiency effects; Promising for therapeutic use

The story of thiamine and the brain stretches back over a century and represents, as one research team put it, “the earliest and perhaps best example of an interaction between nutrition and dementia” [4].

What makes the thiamine story particularly striking is the overlap between classical thiamine deficiency and Alzheimer’s disease. Both conditions show the same pattern: cognitive deficits and a measurable reduction in how efficiently the brain metabolises glucose, its primary fuel [4]. The thiamine-dependent enzymes responsible for brain energy metabolism are reduced not only in people with thiamine deficiency, but also in the brains of Alzheimer’s patients.

In animal studies, and this is where the science is currently strongest, reduced thiamine intake has been shown to drive Alzheimer’s-like changes including memory deficits, the formation of neuritic plaques (the protein clumps associated with Alzheimer’s), and abnormal changes to tau protein [4]. Conversely, excess thiamine in these models *reduced* Alzheimer’s-like pathology.

The honest caveat: most of this mechanistic evidence comes from animal and laboratory studies, and we don’t yet have large-scale RCTs confirming that thiamine supplementation can treat or prevent Alzheimer’s in humans. But the biological logic is coherent and the evidence for *deficiency* causing neurological harm in humans is beyond dispute.

Finding 2: Folate, B12 and B6, The Homocysteine Connection

Evidence grade: Strong for the association; Promising for the intervention

Across the epidemiological literature, the large population studies tracking hundreds of thousands of people over decades, the relationship between low B vitamin status, elevated homocysteine, and cognitive decline is one of the most consistent findings in nutritional science [6].

A 2010 review of the aging brain literature put it clearly: in elderly populations, cognitive impairment and dementia risk are associated with both inadequate B vitamin status and elevated plasma homocysteine [2]. The mechanisms are plausible and multiple, homocysteine is directly neurotoxic, damages the blood vessels that supply the brain, and impairs the methylation reactions that the central nervous system depends on for its daily maintenance [2].

The critical question, can supplementing with B vitamins actually *lower* homocysteine and thereby protect the brain?, has been tested in clinical trials. The short answer: yes, B vitamins reliably lower homocysteine. The bigger question is whether lowering homocysteine translates into measurable brain protection, and here the evidence is more nuanced.

Finding 3: B Vitamins Can Slow Brain Shrinkage, In the Right People

Evidence grade: Promising, one landmark RCT with important caveats

One of the most striking findings in this field came from Oxford University researchers, published in the *Proceedings of the National Academy of Sciences* in 2013 [9].

In a randomised controlled trial of elderly adults with mild cognitive impairment (a recognised risk state for Alzheimer’s disease), participants were given either a high-dose B vitamin combination, folic acid (0.8mg), vitamin B6 (20mg) and vitamin B12 (0.5mg), or a placebo, for two years. Brain MRI scans were taken at the start and end of the study.

The results were remarkable. B vitamin treatment reduced shrinkage in the specific grey matter regions most vulnerable to the Alzheimer’s disease process, including the medial temporal lobe and hippocampus, by as much as *sevenfold* compared to placebo [9].

But here is the crucial detail: the benefit was almost entirely confined to participants who had *elevated homocysteine at baseline* (above 11 µmol/L). In those participants, the chain of cause and effect was clear: B vitamins lowered homocysteine → homocysteine reduction led to less grey matter atrophy → less atrophy was associated with slower cognitive decline [9].

For people with normal homocysteine, the benefit was minimal. This is not a failure of the research, it is a genuinely useful finding. It tells us *who* is most likely to benefit.

The sample was 168 participants over two years. Larger replication studies are needed, but the biological coherence and effect size make this one of the most compelling trials in the field.

Finding 4: The Overall Picture, Small but Real Cognitive Benefit

Evidence grade: Strong (high-certainty evidence), with important nuance about effect size

Vitacuity analyses over 1.77 million research papers, and the most relevant synthesis of the B vitamin and cognition literature comes from a comprehensive 2025 systematic review and meta-analysis published in *Nutrition Reviews*, the largest and most methodologically rigorous analysis to date [1, 10].

The researchers searched five major databases, identified 17 randomised controlled trials meeting strict criteria, and pooled data from 5,275 participants aged 60 and over. All trials ran for at least 26 weeks and involved B6, B9 or B12 supplementation.

Here is where intellectual honesty matters: the headline result, a “small to moderate” improvement in global cognitive function (Hedges’ g = 0.423), came with enormous variability between studies (I² = 92.71%), and was graded as very low certainty once that variability was accounted for.

When the researchers removed statistical outliers and methodologically weaker (single-blinded) studies, the picture became cleaner and more trustworthy. The effect size was smaller, a Hedges’ g of 0.110, but the certainty rating rose to *high*, with negligible variability between studies (I² = 15.39%) [1, 10].

What does a g of 0.110 mean in plain English? It is a small but real, statistically significant improvement, not a dramatic transformation, but a measurable, high-certainty benefit. And crucially, this benefit appeared consistent whether participants had normal cognition, mild cognitive impairment, or dementia [1, 10].

The practical implication: B vitamin supplementation produces a modest but reliably positive effect on cognitive function in older adults. The earlier evidence about who benefits most (those with elevated homocysteine) helps explain why the effect isn’t larger across the whole population, not everyone has the deficiency driving the decline.

Finding 5: B Vitamins and Mental Health, Beyond Cognition

Evidence grade: Promising

The brain implications of B vitamin status don’t stop at memory and thinking speed. A 2016 review examining the role of B vitamins in depression found that vitamins B1, B3, B6, B9 and B12 are all essential for neuronal function, and that deficiencies in each have been linked to depressive symptoms [7].

The mechanisms are logical: B vitamins are required for the methylation cycle and for the production of monoamine neurotransmitters, the chemical messengers including serotonin, dopamine and norepinephrine that regulate mood [7]. They also play a role in mitochondrial function and in managing the inflammatory and stress responses that are increasingly understood to underlie depression.

Meanwhile, B6 deficiency specifically has been shown to hyperactivate the noradrenergic system, the brain’s stress-signalling pathway, leading not only to cognitive impairment but to social deficits [8]. This research, while currently based largely on animal models with observations in specific patient populations, adds an important dimension to the B vitamin story: these nutrients influence not just how sharply we think, but how we feel and how we connect.

Finding 6: Deficiency Is the Key Driver, Supplementing a Sufficient Diet Does Less

Evidence grade: Strong

A 1995 study examining the relationship between vitamin status and mental performance delivered a finding that is just as relevant today as it was three decades ago [3].

In groups where chronically insufficient B vitamin status was confirmed through repeated measurements, covering thiamine, riboflavin, B12 and folate, multiple unfavourable outcomes in cognitive and behavioural measures were consistently observed. When those deficient individuals were supplemented, improvement in cognitive function and behaviour was seen.

But, and this is an important but, supplementing people who already had *sufficient* vitamin status produced no additional cognitive improvement [3].

This is not a reason for pessimism. It is a reason for precision. The research is telling us something genuinely useful: B vitamins matter enormously when you need them, and the biggest gains come from correcting deficiency, not from loading up beyond sufficiency. The question then becomes: how common is inadequate B vitamin status in the population most at risk?

The answer, based on the broader literature, is: more common than most people assume, particularly for B12, folate and B6 in adults over 60, due to declining absorption with age [2].

What We Don’t Know Yet

Honesty is foundational to how we work at Vitacuity, so here is a clear-eyed account of where the science still has gaps.

Why do the trials conflict? The 2025 meta-analysis confirms that prior inconsistency in the literature was driven largely by methodological issues, single-blinded designs and statistical outliers, rather than genuine disagreement about whether B vitamins work [1]. Once those studies were removed, the evidence became consistent. But this also means we need more well-designed, double-blinded trials before we can be fully confident.

Who benefits most is not yet fully mapped. The Oxford brain atrophy trial strongly suggests that people with elevated homocysteine get most of the benefit [9]. But we don’t yet know the precise homocysteine threshold for supplementation to be most effective, or whether different doses of B vitamins matter across different populations.

The thiamine-Alzheimer’s connection needs human trial data. The mechanistic and animal evidence linking thiamine deficiency to Alzheimer’s-like pathology is compelling, but large-scale RCTs testing thiamine supplementation in Alzheimer’s patients are still needed [4].

Effect sizes are modest in the general population. The high-certainty evidence from the 2025 meta-analysis shows a real but small overall benefit (g = 0.110) [1]. This is meaningful, especially for a cheap, safe intervention, but it is not a cure or a guarantee. It is a piece of the puzzle.

Long-term outcomes remain uncertain. Most trials run for one to two years. We do not yet have data on whether sustained B vitamin supplementation over five, ten or twenty years meaningfully reduces dementia incidence at a population level.

B vitamin supplementation and depression is supported by plausible mechanisms and associational data, but the direct clinical trial evidence for mood benefits specifically is still developing [7].

The Final Takeaway

Here is the journey this research has taken us on: from wartime rationing revealing that nutritional deficiency damages the brain, through decades of epidemiology confirming that low B vitamin status is associated with cognitive decline, to randomised controlled trials showing that supplementation can slow brain shrinkage and produce a small but real, high-certainty improvement in cognitive function in older adults.

That is not a story of conflicted evidence leading nowhere. That is a story of science gradually, honestly, mapping a genuine truth.

So what should a sensible, well-informed person in their 40s, 50s or 60s actually do?

Take a B complex supplement daily. B vitamins, B1, B6, B9 (folate) and B12, are water-soluble. Your body does not store them long-term. Any excess is excreted in your urine. There is no meaningful risk of toxicity at standard supplement doses. The risk of being subtly deficient, particularly in B12 and folate as you age and absorption declines, is far more real than the risk of supplementing [2]. This is exactly the category of nutrient where supplementation is the safe, practical default.

Pay attention if you’re over 60. Absorption of B12 from food declines with age, often significantly. The research on both homocysteine and brain atrophy was conducted in older adults for a reason, this is the population where inadequate B vitamin status is most prevalent and most consequential [2, 9].

If you can, check your homocysteine. The Oxford trial’s finding that the brain-protective benefit of B vitamins was concentrated in people with homocysteine above 11 µmol/L is the most actionable piece of information in this research [9]. A homocysteine blood test is relatively affordable and can tell you whether you’re in the group most likely to benefit substantially. But if testing isn’t accessible to you, the case for supplementing is still sound, the 2025 meta-analysis found benefit across all cognitive classifications, not just in the high-homocysteine group [1].

Don’t think of this as a magic pill. The effect sizes are modest, not miraculous. But modest, consistent protection against brain shrinkage, compounded over decades, at the cost of a few pence a day, is exactly the kind of low-drama, high-value intervention that intelligent health decisions are made of.

Eat your B vitamins too. Leafy greens for folate. Eggs, fish and dairy for B12. Wholegrains and legumes for B1 and B6. Supplementation supports your diet, it doesn’t replace it.

The scientists who noticed wartime malnutrition affecting cognition in 1940 didn’t know they were laying the groundwork for eighty years of brain health research. But here we are, with high-certainty evidence that these vitamins matter for your brain, clear mechanisms explaining why, and a supplement that costs almost nothing and carries almost no risk.

That feels like a very good place to have arrived.

References

[1] Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults: A Systematic Review and Meta-analysis (2025). *Nutrition Reviews*. DOI: 10.1093/nutrit/nuaf155 | https://pubmed.ncbi.nlm.nih.gov/40966571/

[2] B vitamins and the aging brain (2010). https://pubmed.ncbi.nlm.nih.gov/21091944/

[3] Interaction of vitamins with mental performance (1995). https://pubmed.ncbi.nlm.nih.gov/8779650/

[4] Vitamin B1 (thiamine) and dementia (2016). https://pubmed.ncbi.nlm.nih.gov/26971083/

[5] Behavioral profile of vitamin B (2022). DOI: 10.1016/bs.vh.2022.02.002 | https://pubmed.ncbi.nlm.nih.gov/35337627/

[6] B-vitamins for neuroprotection: narrowing the evidence gap (2012). https://pubmed.ncbi.nlm.nih.gov/22419558/

[7] The Effects of Vitamin B in Depression (2016). https://pubmed.ncbi.nlm.nih.gov/27655070/

[8] Vitamin B6 deficiency hyperactivates the noradrenergic system, leading to social deficits and cognitive impairment (2021). DOI: 10.1038/s41398-021-01381-z | https://pubmed.ncbi.nlm.nih.gov/33941768/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093222/

[9] Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment (2013). *Proceedings of the National Academy of Sciences*. https://pubmed.ncbi.nlm.nih.gov/23690582/

[10] Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults: A Systematic Review and Meta-analysis (2025). *Nutrition Reviews*. DOI: 10.1093/nutrit/nuaf155 | https://pubmed.ncbi.nlm.nih.gov/40966571/

This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.